K James
University of Oxford
8 Papers
K James is an academic researcher from University of Oxford. The author has contributed to research in topics: Shotgun sequencing & Genome. The author has an hindex of 1, co-authored 8 publications. Previous affiliations of K James include Wellcome Trust Centre for Human Genetics.
Chat about Author
Papers
Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes.
Nozomi Kuse,Hayato Murakoshi,Tomohiro Akahoshi,Takayuki Chikata,K James,Hiroyuki Gatanaga,Sarah Rowland-Jones,Sarah Rowland-Jones,Shinichi Oka,Masafumi Takiguchi +9 more
TL;DR: In this paper, HLA-B*35:01-restricted mutant-specific and cross-reactive T cells were elicited in individuals infected with the Nef135F mutant virus.
4
Low-bias rna sequencing of the hiv-2 genome from blood plasma
K James,Thushan I de Silva,Katherine A. Brown,Hilton Whittle,Stephen Taylor,Gilean McVean,Joakim Esbjörnsson,Sarah Rowland-Jones +7 more
TL;DR: This study demonstrates that RNA-Seq is a feasible full-genome de novo sequencing method for blood plasma samples collected from HIV-2 infected individuals and generates a dynamic picture of genetic diversity over the whole genome of HIV- 2 in the context of low-bias sequencing.
KIR3DL1*0040102 – a novel three-domain KIR subtype isolated from donors of African descent.
TL;DR: KIR3DL1*0040102 allele differs from KIR3 DL1*040101 by a single-nucleotide change at position 12356 (intron 6)
Genomic full length sequence of a novel killer-cell immunoglobulin-like receptor, KIR3DL1*0010103 identified by sequencing.
TL;DR: KIR3DL1*0010103 differs from KIR3 DL1*010101 with four single nucleotide polymorphisms with three single nucleophile polymorphisms.
Low-bias rna sequencing of the hiv-2 genome from blood plasma.
K James,K James,Thushan I de Silva,Thushan I de Silva,Katherine A. Brown,Hilton Whittle,Stephen Taylor,Gilean McVean,Joakim Esbjörnsson,Joakim Esbjörnsson,Sarah Rowland-Jones +10 more
TL;DR: This study demonstrates that RNA-Seq is a feasible full-genome de novo sequencing method for blood plasma samples collected from HIV-2-infected individuals.